Search
Search Results
-
No standard modifiable cardiovascular risk factors in acute myocardial infarction: prevalence, pathophysiology, and prognosis
Standard modifiable cardiovascular risk factors (SMuRFs), such as hypertension, diabetes, dyslipidemia, and current smoking, are associated with the...
-
Long-term outcome of patients presenting with myocardial injury or myocardial infarction
AimsPatients with acute or chronic myocardial injury are frequently identified in the context of suspected myocardial infarction (MI). We aimed to...
-
A cross-sectional study determining prevalence and factors associated with ST-segment elevation myocardial infarction and non-ST segment elevation myocardial infarction in Iran: results from fasa registry on acute myocardial infarction (FaRMI)
BackgroundAcute myocardial infarction is still a leading cause of death worldwide, accounting for roughly three million deaths yearly. This study...
-
Cardiovascular and psychosocial risks among patients below age 50 with acute myocardial infarction
BackgroundDespite improvements in the treatment and prevention of cardiovascular disease since the 1960s, the incidence of cardiovascular diseases...
-
Quantitation of diffuse myocardial ischemia with mental stress and its association with cardiovascular events in individuals with recent myocardial infarction
Microcirculatory dysfunction during psychological stress may lead to diffuse myocardial ischemia. We developed a novel quantification method for...
-
Donepezil attenuates progression of cardiovascular remodeling and improves prognosis in spontaneously hypertensive rats with chronic myocardial infarction
The acetylcholinesterase inhibitor donepezil restores autonomic balance, reduces inflammation, and improves long-term survival in rats with chronic...
-
The national moroccan registry of ST-elevation myocardial infarction (MR-MI)
BackgroundMR-MI is the first national Moroccan ST-elevation myocardial infarction (STEMI) registry. Its objectives are to assess patient management...
-
Long-term cardiovascular prognosis of patients with type 1 diabetes after myocardial infarction
BackgroundTo explore long-term cardiovascular prognosis after myocardial infarction (MI) among patients with type 1 diabetes.
Methods ...
-
Heme Oxygenase-1, Cardiac Senescence, and Myocardial Infarction: A Critical Review of the Triptych
PurposeHeme oxygenase-1 (HO-1) is a crucial enzyme in heme metabolism, facilitating the breakdown of heme into biliverdin, carbon monoxide, and free...
-
Using the Super Learner algorithm to predict risk of major adverse cardiovascular events after percutaneous coronary intervention in patients with myocardial infarction
BackgroundThe primary treatment for patients with myocardial infarction (MI) is percutaneous coronary intervention (PCI). Despite this, the incidence...
-
Recurrent Atherosclerotic Cardiovascular Disease Events Potentially Prevented with Guideline-Recommended Cholesterol-Lowering Therapy following Myocardial Infarction
PurposeMany adults with atherosclerotic cardiovascular disease (ASCVD) who are recommended to take a statin, ezetimibe and/or a proprotein convertase...
-
Pharmacotherapy and cardiovascular challenges: a case report of olverembatinib-induced myocardial infarction with non-obstructive coronary arteries
The anticancer drug of tyrosine kinase-inhibitors (TKIs) has significantly improved the prognosis of patients with specific leukemia but has also...
-
Cardiovascular risks before myocardial infarction differences between men and women
BackgroundProdromal cardiac symptoms are warning signals preceding cardiac disease. Previous studies have shown some gender differences in prodromal...
-
Risk factors for mortality in post-myocardial infarction patients: insights from the improve SCA bridge study
BackgroundUnderutilization of implantable cardioverter defibrillators (ICD) to prevent sudden cardiac death (SCD) in post-myocardial infarction (MI)...
-
Exploring Cutting-Edge Approaches to Potentiate Mesenchymal Stem Cell and Exosome Therapy for Myocardial Infarction
Cardiovascular diseases (CVDs) continue to be a significant global health concern. Many studies have reported promising outcomes from using MSCs and...
-
Prognostic utility of a multi-biomarker panel in patients with suspected myocardial infarction
BackgroundThe accurate identification of patients with high cardiovascular risk in suspected myocardial infarction (MI) is an unmet clinical need....
-
The phagocytic role of macrophage following myocardial infarction
Myocardial infarction (MI) is one of the cardiovascular diseases with high morbidity and mortality. MI causes large amounts of apoptotic and necrotic...
-
Atrial Fibrillation Complicating Acute Myocardial Infarction: Prevalence, Impact, and Management Considerations
Purpose of ReviewAtrial fibrillation (AF) and myocardial infarction (MI) often coexist, and this overlap** nature leads to heightened morbidity and...
-
Urinary cadmium was linearly and positively associated with cardiac infarction/injury score and subclinical myocardial injury in the general population without cardiovascular diseases and chronic kidney disease
PurposeThe study was to investigate the association between urinary cadmium with cardiac infarction/injury score (CIIS) and subclinical myocardial...
-
Very high HDL-C (high-density lipoprotein cholesterol) is associated with increased cardiovascular risk in patients with NSTEMI (non-ST-segment elevation myocardial infarction) undergoing PCI (percutaneous coronary intervention)
BackgroundStudies in populations with or without cardiovascular disease have shown that very high HDL-C levels are associated with an increased risk...
